-
1
-
-
0033964872
-
Lipodystrophies
-
Garg A. Lipodystrophies. Am J Med. 2000;108:143-52.
-
(2000)
Am J Med
, vol.108
, pp. 143-152
-
-
Garg, A.1
-
2
-
-
1542510700
-
Medical progress: Acquired and inherited lipodystrophies
-
Garg A. Medical progress: acquired and inherited lipodystrophies. N Engl J Med. 2004;350(12):1220-34.
-
(2004)
N Engl J Med
, vol.350
, Issue.12
, pp. 1220-1234
-
-
Garg, A.1
-
3
-
-
2542443652
-
Lipodystrophies: Rare disorders causing metabolic syndrome
-
Garg A, Misra A. Lipodystrophies: rare disorders causing metabolic syndrome. Endocrinol Metab Clin North Am. 2004;33:305-31.
-
(2004)
Endocrinol Metab Clin North Am
, vol.33
, pp. 305-331
-
-
Garg, A.1
Misra, A.2
-
4
-
-
80655145234
-
Clinical review#: Lipodystrophies: Genetic and acquired body fat disorders
-
Garg AJ. Clinical review#: Lipodystrophies: genetic and acquired body fat disorders. Clin Endocrinol Metab. 2011;96(11):3313-25.
-
(2011)
Clin Endocrinol Metab
, vol.96
, Issue.11
, pp. 3313-3325
-
-
Garg, A.J.1
-
5
-
-
0036093225
-
Serum adiponectin and leptin levels in patients with lipodystrophies
-
Haque WA, Shimomura I, Matsuzawa Y, Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab. 2002;87(5):2395.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, Issue.5
, pp. 2395
-
-
Haque, W.A.1
Shimomura, I.2
Matsuzawa, Y.3
Garg, A.4
-
6
-
-
0037209124
-
Issues in hyperlipidemic pancreatitis
-
Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol. 2003;36(1):54-62.
-
(2003)
J Clin Gastroenterol
, vol.36
, Issue.1
, pp. 54-62
-
-
Yadav, D.1
Pitchumoni, C.S.2
-
7
-
-
68449089522
-
Inherited lipodystrophies and hypertriglyceridemia
-
Simha V, Garg A. Inherited lipodystrophies and hypertriglyceridemia Curr Opin Lipidol. 2009;20(4):300-8.
-
(2009)
Curr Opin Lipidol
, vol.20
, Issue.4
, pp. 300-308
-
-
Simha, V.1
Garg, A.2
-
8
-
-
0344442411
-
Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy due to mutations in the AGPAT2 or Seipin genes
-
Simha V, Garg A. Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy due to mutations in the AGPAT2 or Seipin genes. J Clin Endocrinol Metab. 2003;88:5433-7.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 5433-5437
-
-
Simha, V.1
Garg, A.2
-
9
-
-
51449114051
-
Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability
-
Simha V, Agarwal AK, Aronin PA, Iannaccone ST, Garg A. Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability. Am J Med Genet A. 2008;146A:2318-26.
-
(2008)
Am J Med Genet A
, vol.146 A
, pp. 2318-2326
-
-
Simha, V.1
Agarwal, A.K.2
Aronin, P.A.3
Iannaccone, S.T.4
Garg, A.5
-
10
-
-
68449089522
-
Inherited lipodystrophies and hypertriglyceridemia
-
Simha V, Garg A. Inherited lipodystrophies and hypertriglyceridemia. Curr Opin Lipidol. 2009;20(4):300-8.
-
(2009)
Curr Opin Lipidol
, vol.20
, Issue.4
, pp. 300-308
-
-
Simha, V.1
Garg, A.2
-
11
-
-
84890612894
-
Berardinelli Seip syndrome with insulin-resistant diabetes mellitus and stroke in an infant
-
Indumathi CK, Lewin S, Ayyar V. Berardinelli Seip syndrome with insulin-resistant diabetes mellitus and stroke in an infant. Indian J Endocrinol Metab. 2011;15(Suppl 1):S62-4.
-
(2011)
Indian J Endocrinol Metab
, vol.15
, Issue.1 SUPPL.
-
-
Indumathi, C.K.1
Lewin, S.2
Ayyar, V.3
-
12
-
-
34247129908
-
Drug therapy of high-risk lipid abnormalities in children and adolescents: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing
-
McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007;115(14):1948-67.
-
(2007)
Circulation
, vol.115
, Issue.14
, pp. 1948-1967
-
-
McCrindle, B.W.1
Urbina, E.M.2
Dennison, B.A.3
Jacobson, M.S.4
Steinberger, J.5
Rocchini, A.P.6
-
13
-
-
60149091851
-
Prevenção da aterosclerose e tratamento medicamentoso de anormalidades lipídicas de alto risco em crianças e adolescentes
-
Castro PSG, Oliveira FLC. Prevenção da aterosclerose e tratamento medicamentoso de anormalidades lipídicas de alto risco em crianças e adolescentes. J Pediatr (Rio J). 2009;85(1):6-14.
-
(2009)
J Pediatr (Rio J)
, vol.85
, Issue.1
, pp. 6-14
-
-
Castro, P.S.G.1
Oliveira, F.L.C.2
-
14
-
-
34247471569
-
Hypertriglyceridemia: Its etiology, effects and treatment
-
Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ. 2007;176(8):1113-20.
-
(2007)
CMAJ
, vol.176
, Issue.8
, pp. 1113-1120
-
-
Yuan, G.1
Al-Shali, K.Z.2
Hegele, R.A.3
-
15
-
-
0030658022
-
Coordinate regulation of the expression of the fatty acid transporter protein (FATP) and acyl CoA synthetase (ACS) genes by PPARa and PPARg activators
-
Martin G, Schoonjans K, Lefebvre A, Staels B, Auwerx J. Coordinate regulation of the expression of the fatty acid transporter protein (FATP) and acyl CoA synthetase (ACS) genes by PPARa and PPARg activators. J Biol Chem. 1997;272:28210-7.
-
(1997)
J Biol Chem
, vol.272
, pp. 28210-28217
-
-
Martin, G.1
Schoonjans, K.2
Lefebvre, A.3
Staels, B.4
Auwerx, J.5
-
16
-
-
0030024585
-
Carcinogenicity of lipid-lowering drugs
-
Newman T, Hulley S. Carcinogenicity of lipid-lowering drugs. JAMA. 1996;275:55-60.
-
(1996)
JAMA
, vol.275
, pp. 55-60
-
-
Newman, T.1
Hulley, S.2
-
17
-
-
0026212784
-
Side effects of fibrates (except liver and muscle)
-
Sgro C, Escousse A. Side effects of fibrates (except liver and muscle). Therapie. 1991;46:351-4.
-
(1991)
Therapie
, vol.46
, pp. 351-354
-
-
Sgro, C.1
Escousse, A.2
-
18
-
-
42249113454
-
Fibrate therapy: An update
-
Remick J, Weintraub H, Setton R, Offenbacher J, Fisher E, Schwartzbard A. Fibrate therapy: an update. Cardiol Rev. 2008;16:129-41.
-
(2008)
Cardiol Rev
, vol.16
, pp. 129-141
-
-
Remick, J.1
Weintraub, H.2
Setton, R.3
Offenbacher, J.4
Fisher, E.5
Schwartzbard, A.6
-
19
-
-
0026514173
-
Severe gastrointestinal bleeding induced by a probable hydroxycoumarin-bezafibrate interaction
-
Blum A, Seligmann H, Livneh A, Ezra D. Severe gastrointestinal bleeding induced by a probable hydroxycoumarin-bezafibrate interaction. Isr J Med Sci. 1992;28:47-9.
-
(1992)
Isr J Med Sci
, vol.28
, pp. 47-49
-
-
Blum, A.1
Seligmann, H.2
Livneh, A.3
Ezra, D.4
-
20
-
-
0021964325
-
Double blind trial of bezafibrate in familial hypercholesterolaemia
-
Wheeler KA, West RJ, Lloyd JK, Barley J. Double blind trial of bezafibrate in familial hypercholesterolaemia. Arch Dis Child. 1985;60(1):34-7.
-
(1985)
Arch Dis Child
, vol.60
, Issue.1
, pp. 34-37
-
-
Wheeler, K.A.1
West, R.J.2
Lloyd, J.K.3
Barley, J.4
|